PLN and heart disorder: Until then, other modalities that show promise such as PLN-ASOs and PLN siRNAs make great alternatives as a treatment strategy for genetic heart disease, as they have proven to be an effective treatment for PLN R14del and other etiologies of heart disease in vivo and in vitro [51, 52, 53, 54•].